CoChat

The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation status

Open access
Mohammed, Fiyaz, Stones, Daniel H., Zarling, Angela L., Willcox, Carrie R., Shabanowitz, Jeffrey, Cummings, Kara L., Hunt, Donald F., Cobbold, Mark, Engelhard, Victor H., Willcox, Benjamin E. · 2017 · Oncotarget
Cited by 56

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

// Fiyaz Mohammed 1, * , Daniel H. Stones 1, * , Angela L. Zarling 2 , Carrie R. Willcox 1 , Jeffrey Shabanowitz 3 , Kara L. Cummings 2 , Donald F. Hunt 3 , Mark Cobbold 4, 5, 6 , Victor H. Engelhard 2 and Benjamin E. Willcox 1 1 Cancer Immunology and Immunotherapy Centre, Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK 2 Carter Immunology Center and Department of Microbiology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA 3 Department of Chemistry, University of Virginia, Charlottesville, Virginia 22908, USA 4 School of Immunity and Infection, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK 5 Current address: Cancer Centre, Massachusetts General Hospital, Boston, Massachusetts 02114, USA 6 Current address: Department of Medicine, Harvard Medical School, Charlestown, Massachusetts 02129, USA * These authors contributed equally to this work Correspondence to: Benjamin E. Willcox, email: b.willcox@bham.ac.uk Keywords: tumour immunology, phosphopeptide, peptide-MHC complex, neoepitope, peptide conformation Received: February 17, 2017 Accepted: March 30, 2017 Published: April 08, 2017 ABSTRACT Dysregulated post-translational modification provides a source of altered self-antigens that can stimulate immune responses in autoimmunity, inflammation, and cancer. In recent years, phosphorylated peptides have emerged as a group of tumour-associated antigens presented by MHC molecules and recognised by T cells, and represent promising candidates for cancer immunotherapy. However, the impact of phosphorylation on the antigenic identity of phosphopeptide epitopes is unclear. Here we examined this by determining structures of MHC-bound phosphopeptides bearing canonical position 4-phosphorylations in the presence and absence of their phosphate moiety, and examining phosphopeptide recognition by the T cell receptor (TCR). Strikingly, two peptides exhibited major conformational changes upon phosphorylation, involving a similar molecular mechanism, which focussed changes on the central peptide region most critical for T cell recognition. In contrast, a third epitope displayed little conformational alteration upon phosphorylation. In addition, binding studies demonstrated TCR interaction with an MHC-bound phosphopeptide was both epitope-specific and absolutely dependent upon phosphorylation status. These results highlight the critical influence of phosphorylation on the antigenic identity of naturally processed class I MHC epitopes. In doing so they provide a molecular framework for understanding phosphopeptide-specific immune responses, and have implications for the development of phosphopeptide antigen-specific cancer immunotherapy approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.16952

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

Metadata

Authors
Mohammed, F., Stones, D. H., Zarling, A. L., Willcox, C. R., Shabanowitz, J., Cummings, K. L., Hunt, D. F., Cobbold, M., Engelhard, V. H., & Willcox, B. E.
Venue
Oncotarget
Published
2017-04-08
Volume
8
Issue
33
Pages
54160-54172
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2604431513
Cited by
56
References
2
FWCI
1.75
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.